Announced in December 2024, David Enloe joins as the division’s CEO. He has experience leading life science CDMOs such as ...

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...

The biotech company, focused on developing treatments for chronic eye conditions, received Food and Drug Administration (FDA) ...

“As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the ...